|Videos|November 8, 2022
The Importance of the Proof-of-Concept Stage while Producing a Glioblastoma Multiform Drug Candidate Video
Author(s)Nanoform
Learn how TargTex partners with Nanoform to produce therapies for Glioblastoma patients. This process includes identifying novel targets with small molecules, utilizing Nanoform technology to increase the active pharmaceutical ingredient [API] concentration, and improving treatment stability to move the drug to clinical development.
Related Content
Trending on Pharmaceutical Technology
1
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
2
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
3
Technology Transfer: Success Drivers and Obstacles Explained
4
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
5